Contraception. 2011 Apr;83(4):295-309. doi: 10.1016/j.contraception.2010.11.006. Epub 2011 Feb 12.
One known complication of induced abortion is upper genital tract infection, which is relatively uncommon in the current era of safe, legal abortion. Currently, rates of upper genital tract infection in the setting of legal induced abortion in the United States are generally less than 1%. Randomized controlled trials support the use of prophylactic antibiotics for surgical abortion in the first trimester. For medical abortion, treatment-dose antibiotics may lower the risk of serious infection. However, the number-needed-to-treat is high. Consequently, the balance of risk and benefits warrants further investigation. Perioperative oral doxycycline given up to 12 h before a surgical abortion appears to effectively reduce infectious risk. Antibiotics that are continued after the procedure for extended durations meet the definition for a treatment regimen rather than a prophylactic regimen. Prophylactic efficacy of antibiotics begun after abortion has not been demonstrated in controlled trials. Thus, the current evidence supports pre-procedure but not post-procedure antibiotics for the purpose of prophylaxis. No controlled studies have examined the efficacy of antibiotic prophylaxis for induced surgical abortion beyond 15 weeks of gestation. The risk of infection is not altered when an intrauterine device is inserted immediately post-procedure. The presence of Chlamydia trachomatis, Neisseria gonorrhoeae or acute cervicitis carries a significant risk of upper genital tract infection; this risk is significantly reduced with antibiotic prophylaxis. Women with bacterial vaginosis (BV) also have an elevated risk of post-procedural infection as compared with women without BV; however, additional prophylactic antibiotics for women with known BV has not been shown to reduce their risk further than with use of typical pre-procedure antibiotic prophylaxis. Accordingly, evidence to support pre-procedure screening for BV is lacking. Neither povidone-iodine nor chlorhexidine have been shown to alter the risk of infection when used as cervicovaginal preparation. However, chlorhexidine appears to be more effective than povidone iodine at reducing bacteria within the vagina. The Society of Family Planning recommends the routine use of antibiotic prophylaxis, preferably with doxycycline, before surgical abortion. Use of treatment doses of antibiotics with medical abortion may decrease the rare risk of serious infection but universal requirement for such treatment has not been established.
人工流产的一个已知并发症是上生殖道感染,在当前安全、合法的人工流产时代,这种感染相对较少见。目前,在美国合法人工流产中,上生殖道感染的发生率一般低于 1%。随机对照试验支持在孕早期行手术流产时预防性使用抗生素。对于药物流产,治疗剂量的抗生素可能会降低严重感染的风险。然而,需要治疗的人数很多。因此,风险与收益的平衡需要进一步研究。在手术流产前 12 小时内给予预防性口服多西环素似乎可以有效降低感染风险。手术后延长疗程使用抗生素也符合治疗方案而非预防方案的定义。在对照试验中,未证明流产后使用抗生素具有预防效果。因此,目前的证据支持手术流产前使用抗生素而不是手术后使用抗生素进行预防。没有对照研究检查过在妊娠 15 周以上行人工诱导性流产时使用抗生素预防的效果。手术后立即放置宫内节育器不会改变感染的风险。如果存在沙眼衣原体、淋病奈瑟菌或急性宫颈炎,上生殖道感染的风险显著增加;使用抗生素预防可显著降低这种风险。与无细菌性阴道病(BV)的女性相比,BV 女性术后感染的风险也更高;然而,对于已知患有 BV 的女性,额外使用预防性抗生素并不能进一步降低其风险,与使用典型的术前预防性抗生素预防相比没有更多益处。因此,缺乏支持术前筛查 BV 的证据。聚维酮碘或氯己定用作宫颈阴道准备时,均未显示会增加感染风险。然而,氯己定似乎比聚维酮碘更能有效减少阴道内的细菌。计划生育协会建议在手术流产前常规使用抗生素预防,最好使用多西环素。对于药物流产,使用治疗剂量的抗生素可能会降低罕见的严重感染风险,但尚未确定是否需要普遍采用这种治疗。